(Q44202473)

30 November 2017

title

Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases (English)

1 reference

30 November 2017

0 references

1 reference

1 reference

1 reference

Tianling Chen

1

1 reference

30 November 2017

James Berenson

2

1 reference

30 November 2017

Robert Vescio

3

1 reference

30 November 2017

Regina Swift

4

1 reference

30 November 2017

Alicia Gilchick

5

1 reference

30 November 2017

Susan Goodin

6

1 reference

30 November 2017

Patricia LoRusso

7

1 reference

30 November 2017

Peiming Ma

8

1 reference

30 November 2017

Christina Ravera

9

1 reference

30 November 2017

Fabienne Deckert

10

1 reference

30 November 2017

Horst Schran

11

1 reference

30 November 2017

John Seaman

12

1 reference

30 November 2017

Andrej Skerjanec

13

1 reference

30 November 2017

publication date

1 November 2002

1 reference

The Journal of Clinical Pharmacology

30 November 2017

published in

1 reference

30 November 2017

volume

42

1 reference

30 November 2017

issue

11

1 reference

30 November 2017

page(s)

1228-1236

1 reference

Bisphosphonates: a review of their pharmacokinetic properties

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F009127002762491316

Preclinical pharmacology of CGP 42'446, a new, potent, heterocyclic bisphosphonate compound

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127002762491316

Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127002762491316

A Phase I, open label, dose ranging trial of intravenous bolus zoledronic acid, a novel bisphosphonate, in cancer patients with metastatic bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127002762491316

Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127002762491316

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127002762491316

Pharmacokinetics of pamidronate disodium in patients with cancer with normal or impaired renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127002762491316

Effect of renal function on risedronate pharmacokinetics after a single oral dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127002762491316

10.1177/009127002762491316

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference